First Time Loading...

Bionano Genomics Inc
NASDAQ:BNGO

Watchlist Manager
Bionano Genomics Inc Logo
Bionano Genomics Inc
NASDAQ:BNGO
Watchlist
Price: 0.75 USD -1.46% Market Closed
Updated: Apr 25, 2024

Intrinsic Value

BNGO's intrinsic value estimate is unreliable because it is based only on its multiples and doesn't use a DCF valuation.

Bionano Genomics, Inc. is a life sciences instrumentation company, which focuses on the genome analysis space. [ Read More ]

The intrinsic value of one BNGO stock under the Base Case scenario is 4.58 USD. Compared to the current market price of 0.75 USD, Bionano Genomics Inc is Undervalued by 84%.

Key Points:
BNGO Intrinsic Value
Base Case
4.58 USD
Undervaluation 84%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
Bionano Genomics Inc

Backtest Intrinsic Value
Dive into the past to invest in the future

Run backtest to discover the historical profit from buying and selling BNGO stocks based on their intrinsic value.

Analyze the historical link between intrinsic value and market price to make more informed investment decisions.

Run Backtest
Settings
Valuation Methods
Buy/Sell Thresholds
Buy When:
%
Sell When:
%
B
S
Run Backtest
How does it work?

Fundamental Analysis

Beta
Ask me anything about
Bionano Genomics Inc

Provide an overview of the primary business activities
of Bionano Genomics Inc.

What unique competitive advantages
does Bionano Genomics Inc hold over its rivals?

What risks and challenges
does Bionano Genomics Inc face in the near future?

Has there been any significant insider trading activity
in Bionano Genomics Inc recently?

Summarize the latest earnings call
of Bionano Genomics Inc.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Bionano Genomics Inc.

Provide P/S
for Bionano Genomics Inc.

Provide P/E
for Bionano Genomics Inc.

Provide P/OCF
for Bionano Genomics Inc.

Provide P/FCFE
for Bionano Genomics Inc.

Provide P/B
for Bionano Genomics Inc.

Provide EV/S
for Bionano Genomics Inc.

Provide EV/GP
for Bionano Genomics Inc.

Provide EV/EBITDA
for Bionano Genomics Inc.

Provide EV/EBIT
for Bionano Genomics Inc.

Provide EV/OCF
for Bionano Genomics Inc.

Provide EV/FCFF
for Bionano Genomics Inc.

Provide EV/IC
for Bionano Genomics Inc.

Show me price targets
for Bionano Genomics Inc made by professional analysts.

What are the Revenue projections
for Bionano Genomics Inc?

How accurate were the past Revenue estimates
for Bionano Genomics Inc?

What are the Net Income projections
for Bionano Genomics Inc?

How accurate were the past Net Income estimates
for Bionano Genomics Inc?

What are the EPS projections
for Bionano Genomics Inc?

How accurate were the past EPS estimates
for Bionano Genomics Inc?

What are the EBIT projections
for Bionano Genomics Inc?

How accurate were the past EBIT estimates
for Bionano Genomics Inc?

Compare the revenue forecasts
for Bionano Genomics Inc with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Bionano Genomics Inc and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Bionano Genomics Inc against its competitors.

Analyze the profit margins
(gross, operating, and net) of Bionano Genomics Inc compared to its peers.

Compare the P/E ratios
of Bionano Genomics Inc against its peers.

Discuss the investment returns and shareholder value creation
comparing Bionano Genomics Inc with its peers.

Analyze the financial leverage
of Bionano Genomics Inc compared to its main competitors.

Show all profitability ratios
for Bionano Genomics Inc.

Provide ROE
for Bionano Genomics Inc.

Provide ROA
for Bionano Genomics Inc.

Provide ROIC
for Bionano Genomics Inc.

Provide ROCE
for Bionano Genomics Inc.

Provide Gross Margin
for Bionano Genomics Inc.

Provide Operating Margin
for Bionano Genomics Inc.

Provide Net Margin
for Bionano Genomics Inc.

Provide FCF Margin
for Bionano Genomics Inc.

Show all solvency ratios
for Bionano Genomics Inc.

Provide D/E Ratio
for Bionano Genomics Inc.

Provide D/A Ratio
for Bionano Genomics Inc.

Provide Interest Coverage Ratio
for Bionano Genomics Inc.

Provide Altman Z-Score Ratio
for Bionano Genomics Inc.

Provide Quick Ratio
for Bionano Genomics Inc.

Provide Current Ratio
for Bionano Genomics Inc.

Provide Cash Ratio
for Bionano Genomics Inc.

What is the historical Revenue growth
over the last 5 years for Bionano Genomics Inc?

What is the historical Net Income growth
over the last 5 years for Bionano Genomics Inc?

What is the current Free Cash Flow
of Bionano Genomics Inc?

Discuss the annual earnings per share (EPS)
trend over the past five years for Bionano Genomics Inc.

Financials

Balance Sheet Decomposition
Bionano Genomics Inc

Current Assets 140.1m
Cash & Short-Term Investments 66.8m
Receivables 9.7m
Other Current Assets 63.7m
Non-Current Assets 74.3m
PP&E 32.5m
Intangibles 34m
Other Non-Current Assets 7.8m
Current Liabilities 100m
Accounts Payable 10.4m
Accrued Liabilities 9.1m
Other Current Liabilities 80.5m
Non-Current Liabilities 18.2m
Long-Term Debt 3.6m
Other Non-Current Liabilities 14.6m
Efficiency

Earnings Waterfall
Bionano Genomics Inc

Revenue
36.1m USD
Cost of Revenue
-26.6m USD
Gross Profit
9.6m USD
Operating Expenses
-147.5m USD
Operating Income
-138m USD
Other Expenses
-94.5m USD
Net Income
-232.5m USD

Free Cash Flow Analysis
Bionano Genomics Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate
History
Components
Chart
Table
Fundamental Scores

BNGO Profitability Score
Profitability Due Diligence

Bionano Genomics Inc's profitability score is 28/100. The higher the profitability score, the more profitable the company is.

Exceptional 3-Years Revenue Growth
ROIC is Increasing
Exceptional Revenue Growth Forecast
Positive Gross Profit
28/100
Profitability
Score

Bionano Genomics Inc's profitability score is 28/100. The higher the profitability score, the more profitable the company is.

BNGO Solvency Score
Solvency Due Diligence

Bionano Genomics Inc's solvency score is 45/100. The higher the solvency score, the more solvent the company is.

Negative Net Debt
Low D/E
Long-Term Solvency
Short-Term Solvency
45/100
Solvency
Score

Bionano Genomics Inc's solvency score is 45/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

BNGO Price Targets Summary
Bionano Genomics Inc

There are no price targets for BNGO.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates

Competitive Landscape

Ownership

BNGO Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

Shareholder Return

BNGO Price
Bionano Genomics Inc

1M 1M
-27%
6M 6M
-43%
1Y 1Y
-90%
3Y 3Y
-99%
5Y 5Y
-98%
10Y 10Y
-99%
Annual Price Range
0.75
52w Low
0.75
52w High
7.94
Price Metrics
Average Annual Return 75.22%
Standard Deviation of Annual Returns 270.37%
Max Drawdown -100%
Shares Statistics
Market Capitalization 45.9m USD
Shares Outstanding 61 230 700
Percentage of Shares Shorted 9.67%

BNGO Return Decomposition
Main factors of price return

What is price return decomposition?

BNGO News

Other Videos

Company Profile

Bionano Genomics Inc Logo
Bionano Genomics Inc

Country

United States of America

Industry

Life Sciences Tools & Services

Market Cap

45.9m USD

Dividend Yield

0%

Description

Bionano Genomics, Inc. is a life sciences instrumentation company, which focuses on the genome analysis space. The company is headquartered in San Diego, California and currently employs 299 full-time employees. The company went IPO on 2018-08-01. The firm offers diagnostic services to physicians specializing in medical management for individuals with genetic conditions, such as pediatric neurodevelopmental disorders, including autism spectrum disorders. The company markets and sell the Saphyr system, which delivers OGM data to enable ultra-sensitive and ultra-specific detection of all classes of structural variation. Its Lineagen business provides diagnostic testing for patients with clinical presentations consistent with autism spectrum disorder and other neurodevelopmental disabilities. Through its BioDiscovery business, it offers a platform-agnostic software solution, which integrates sequencing and microarray data designed to provide analysis, visualization, interpretation and reporting of copy number variants, single-nucleotide variants and absence of heterozygosity across the genome in one consolidated view.

Contact

CALIFORNIA
San Diego
9540 Towne Centre Dr Ste 100
+18588887600.0
https://bionanogenomics.com/

IPO

2018-08-01

Employees

299

Officers

President, CEO, Secretary & Director
Dr. Robert Erik Holmlin M.B.A., Ph.D.
Chief Operating Officer
Mr. Mark Oldakowski
Chief Medical Officer
Dr. Alka Chaubey FACMG, Ph.D.
Chief Financial Officer
Ms. Gulsen Kama M.B.A.
VP of Accounting & Controller
Mr. Mark Adamchak CPA
General Counsel
Mr. Jonathan Dixon J.D.
Show More
Vice President of Global Sales
Mr. Stanislas Marin M.B.A., M.S.
Global Head of Market Access
Ms. Donna Polizio
Global Head of People Operations
Mr. Cory Kreeck
Head of Research & Development
Dr. Klint Rose Ph.D.
Show Less

See Also

Discover More
What is the Intrinsic Value of one BNGO stock?

The intrinsic value of one BNGO stock under the Base Case scenario is 4.58 USD.

Is BNGO stock undervalued or overvalued?

Compared to the current market price of 0.75 USD, Bionano Genomics Inc is Undervalued by 84%.